Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

SHA:600789 Revenue

Shandong Lukang Pharmaceutical had revenue of 1.62B CNY in the quarter ending March 31, 2026, a decrease of -3.42%. This brings the company's revenue in the last twelve months to 5.71B, down -6.54% year-over-year. In the year 2025, Shandong Lukang Pharmaceutical had annual revenue of 5.77B, down -7.49%.

• Revenue (ttm): 5.71B
• Revenue Growth: -6.54%
• P/S Ratio: 1.48
• Revenue / Employee: 893.69K
• Employees: 6,388
• Market Cap: 8.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.77B	-466.97M	-7.49%
Dec 31, 2024	6.23B	86.37M	1.41%
Dec 31, 2023	6.15B	525.28M	9.34%
Dec 31, 2022	5.62B	697.66M	14.17%
Dec 31, 2021	4.92B	718.67M	17.09%